NEUROCENTRX Trademark

Trademark Overview


On Wednesday, June 28, 2023, a trademark application was filed for NEUROCENTRX with the United States Patent and Trademark Office. The USPTO has given the NEUROCENTRX trademark a serial number of 79381070. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2025. This trademark is owned by Neurocentrx pharma ltd. The NEUROCENTRX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical compositions in the nature of pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, p...

Research relating to medicine; research and development in the field of medicine; development of pharmaceutical preparations and medicines; research relating to medicines
neurocentrx

General Information


Serial Number79381070
Word MarkNEUROCENTRX
Filing DateWednesday, June 28, 2023
Status700 - REGISTERED
Status DateTuesday, January 28, 2025
Registration Number7665514
Registration DateTuesday, January 28, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical compositions in the nature of pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; herbal medicine preparations; implantable medicines, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; capsules for medicines, namely capsules sold empty for pharmaceuticals; medicines for human purposes, namely, pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical skin lotions; pharmaceutical creams for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical preparations in strip form for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; lotions for pharmaceutical purposes for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation
Pseudo MarkNEURO CENTRX
Goods and ServicesResearch relating to medicine; research and development in the field of medicine; development of pharmaceutical preparations and medicines; research relating to medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 20, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocentrx pharma ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameNeurocentrx pharma ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameNeurocentrx pharma ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, October 19, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 24, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, March 27, 2024NON-FINAL ACTION WRITTEN
Wednesday, March 13, 2024ASSIGNED TO EXAMINER
Wednesday, May 8, 2024REFUSAL PROCESSED BY IB
Monday, October 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 28, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 16, 2024REFUSAL PROCESSED BY MPU
Wednesday, April 17, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 28, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED